These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 16876918)
21. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin. Barclay PG; Fischer ER; Harris DC Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716 [TBL] [Abstract][Full Text] [Related]
22. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices. Trkulja V Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846 [TBL] [Abstract][Full Text] [Related]
23. Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Zhou XJ; Vaziri ND Am J Physiol; 1992 Nov; 263(5 Pt 2):F812-5. PubMed ID: 1443172 [TBL] [Abstract][Full Text] [Related]
24. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis]. Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643 [TBL] [Abstract][Full Text] [Related]
25. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
26. Renal clearance of endogenous erythropoietin in patients with proteinuria. Nowicki M; Kokot F; Kokot M; Bar A; Duława J Int Urol Nephrol; 1994; 26(6):691-9. PubMed ID: 7759206 [TBL] [Abstract][Full Text] [Related]
27. Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. Del Prete S; Cinieri S; Lorusso V; Maiorino L; Pizza C; Pisano A; Montesarchio V; Leo L; Savastano C; Pistolese G; Bianco M; Mabilia R; Tonachella R; Febbraro A; Manzione L; Palazzo S; Filippelli G; Vincenzi B; Barbato E; Cennamo G; Riccardi F; Misso G; Caraglia M; Addeo R Future Oncol; 2014 Jan; 10(1):69-78. PubMed ID: 24328410 [TBL] [Abstract][Full Text] [Related]
28. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related]
29. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. Durmaz O; Demirkaya M; Sevinir B Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225 [TBL] [Abstract][Full Text] [Related]
30. [Effectiveness of and tolerance to human recombinant erythropoietin in the treatment of kidney failure anemia in children undergoing continuous peritoneal dialysis. Multicenter study]. Parchoux B; Broyer M; Cochat P; Burguet A; Menget A; Benoît D; Nivet H; Fischbach M; Geisert J; Dabout D Pediatrie; 1993; 48(5):397-401. PubMed ID: 7777395 [TBL] [Abstract][Full Text] [Related]
31. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view]. Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189 [TBL] [Abstract][Full Text] [Related]
32. A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone. Lissoni P; Rovelli F; Baiocco N; Tangini G; Fumagalli L Anticancer Res; 2001; 21(1B):777-9. PubMed ID: 11299843 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis]. García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677 [TBL] [Abstract][Full Text] [Related]
34. Renal anemia: from incurable to curable. Sato Y; Yanagita M Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1239-48. PubMed ID: 23884144 [TBL] [Abstract][Full Text] [Related]
36. Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function. Stuart M Clin Pediatr (Phila); 2002 Jun; 41(5):361. PubMed ID: 12086203 [No Abstract] [Full Text] [Related]
37. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group. Laupacis A Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167 [TBL] [Abstract][Full Text] [Related]
38. Treatment of anaemia in CAPD patients with recombinant human erythropoietin. Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834 [TBL] [Abstract][Full Text] [Related]
39. Biological characterization of recombinant human erythropoietin. Krumwieh D; Arnold I; Seiler FR Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225 [TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin]. Koda K; Hayashi S; Ikeda K; Morita K; Tsuji Y; Takimoto R; Fujisaki Y; Nakazawa O Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]